MSD Pharmaceuticals Private Limited
Inventia to Bioprint Brain Cell Models with Merck Subsidiary for Drug Discovery
Australian bioprinting startup Inventia Life Science and the multinational MSD Pharmaceuticals Private Limited, a wholly-owned subsidiary of Merck Sharp and Dohme known as Merck in the U.S. and Canada, will…
